| Company | Sales | Gross M. | SGA % Sales | R&D % Sales | Trading M. | Tax Rate | Net Income | EPS |
| | | | | | | | |
| Vertex | 19.2% | 0.4% | -11.8% | -14.8% | 23.1% | | 26.7% | 25.4% |
| Takeda | 11.1% | 1.6% | -6.6% | -5.3% | 18.3% | -1.3% | 38.5% | 29.1% |
| Alexion | 11.0% | 0.0% | -2.5% | 1.7% | 0.9% | 1.5% | 12.4% | 13.1% |
| Astra | 9.2% | 0.4% | -5.4% | -6.3% | 16.0% | 10.9% | 16.7% | 16.2% |
| Celgene | 8.1% | -0.4% | -2.5% | -2.2% | 0.6% | 0.7% | 9.8% | 12.0% |
| Regeneron | 6.7% | -0.3% | -1.3% | -2.5% | -2.1% | 28.9% | 6.7% | 5.8% |
| Novo | 6.1% | -0.3% | -1.7% | -1.5% | 0.8% | 1.9% | 6.1% | 8.4% |
| Chugai | 6.0% | 2.4% | -3.3% | -1.0% | 5.8% | 2.2% | 16.0% | 12.4% |
| Bayer | 5.6% | 2.4% | -1.2% | -2.2% | 29.8% | -2.7% | 11.4% | 10.4% |
| Daiichi | 5.2% | 1.9% | -1.9% | -1.1% | 16.3% | 1.8% | 21.1% | 21.2% |
| Glaxo | 4.9% | 0.1% | -0.7% | 1.4% | -0.1% | 0.1% | 3.4% | 3.1% |
| Lilly | 4.8% | 0.4% | -3.1% | -0.7% | 3.3% | -0.6% | 7.9% | 8.9% |
| Bristol | 4.5% | -0.2% | -3.2% | -0.2% | 1.7% | -0.1% | 5.1% | 5.6% |
| Merck | 4.2% | 0.0% | -2.6% | -0.4% | 2.0% | -1.3% | 6.1% | 8.0% |
| Otsuka | 4.1% | 0.7% | -1.3% | -0.8% | 11.4% | -2.3% | 15.8% | 17.9% |
| Merck KG | 3.8% | 0.6% | -1.2% | -2.3% | 7.5% | 1.3% | 7.4% | 7.4% |
| Sanofi | 3.5% | 0.2% | -1.9% | -2.3% | 3.8% | 0.3% | 5.4% | 5.9% |
| AbbVie | 3.2% | 0.0% | -2.2% | -0.9% | 0.7% | 8.2% | 3.9% | 6.0% |
| Mylan | 3.1% | -0.2% | 1.2% | 1.3% | -1.5% | 1.3% | 2.5% | 2.2% |
| Roche | 2.6% | 0.1% | -0.3% | -0.4% | 0.5% | 0.3% | 3.5% | 3.6% |
| Pfizer | 2.6% | 0.2% | -1.8% | -1.0% | 1.7% | 0.4% | 3.6% | 5.3% |
| JnJ | 2.3% | 0.1% | -1.9% | -0.9% | 2.3% | 0.8% | 4.2% | 5.2% |
| Allergan | 2.2% | 0.0% | -0.2% | 0.5% | 0.0% | -0.8% | 4.1% | 5.3% |
| Novartis | 0.7% | 0.7% | -1.7% | 1.4% | 4.1% | 0.3% | 4.9% | 5.6% |
| Gilead | 0.6% | 0.5% | 1.8% | 1.5% | 0.3% | 0.7% | 0.8% | 2.3% |
| Astellas | 0.1% | 0.8% | | 0.4% | | | | |
| Amgen | 0.0% | -0.3% | -1.5% | 1.0% | -0.1% | 1.0% | 0.1% | 3.0% |
| UCB | -0.5% | 0.6% | 0.4% | 0.2% | 1.6% | 0.3% | 2.5% | 2.4% |
| Biogen | -0.6% | -0.1% | 1.5% | -1.0% | -0.3% | -1.8% | 0.0% | 1.7% |
| Lundbeck | -0.8% | 1.0% | 0.8% | 1.7% | 3.2% | -0.5% | -0.5% | -0.3% |
| Teva | -0.9% | 1.0% | -0.2% | -0.9% | 1.5% | 3.2% | 3.6% | 1.5% |
| M Tanabe | -2.0% | -0.8% | -0.1% | 0.2% | -5.5% | -0.9% | -6.2% | -3.9% |
| Shionogi | | | | | | | | |
| Eisai | | | | | | | | |
| ONO | | | | | | | | |
| EU Major | 4.1% | 0.6% | -1.5% | -1.2% | 4.0% | 1.1% | 6.4% | 6.9% |
| Other EU | 2.5% | 0.5% | -0.5% | -1.6% | 4.3% | 1.2% | 5.1% | 3.9% |
| US Major | 3.2% | 0.1% | -2.3% | -0.5% | 1.9% | 0.8% | 4.7% | 6.5% |
| US Big Biotech | 3.6% | 0.1% | -1.2% | -0.7% | 0.7% | 6.8% | 4.7% | 6.7% |
| Other US | 1.2% | 0.4% | 0.2% | 0.4% | 0.3% | 0.8% | 3.6% | 4.3% |
| Japanese | 5.9% | 1.2% | -2.8% | -2.4% | 13.8% | -1.3% | 22.8% | 17.2% |